Profile data is unavailable for this security.
About the company
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
- Revenue in USD (TTM)127.41m
- Net income in USD84.00k
- Incorporated2005
- Employees499.00
- LocationInfuSystem Holdings Inc3851 West Hamlin RoadROCHESTER HILLS 48309United StatesUSA
- Phone+1 (248) 291-1210
- Websitehttps://ir.infusystem.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asensus Surgical Inc | 8.72m | -78.71m | 91.43m | 207.00 | -- | 7.01 | -- | 10.48 | -0.3065 | -0.3065 | 0.0339 | 0.0479 | 0.1271 | 1.79 | 13.09 | 42,144.93 | -114.63 | -71.10 | -146.89 | -79.04 | -52.04 | -71.39 | -902.25 | -1,207.71 | 0.689 | -- | 0.00 | -- | 21.02 | -18.67 | -3.80 | -- | -6.14 | -- |
| Akoya Biosciences Inc | 93.57m | -68.01m | 105.19m | 330.00 | -- | 3.21 | -- | 1.12 | -1.47 | -1.47 | 1.99 | 0.6632 | 0.6056 | 2.20 | 7.08 | 283,554.50 | -44.01 | -- | -56.06 | -- | 55.99 | -- | -72.68 | -- | 2.38 | -10.15 | 0.7013 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| TELA Bio Inc | 63.15m | -40.30m | 107.25m | 227.00 | -- | 7.46 | -- | 1.70 | -1.67 | -1.67 | 2.61 | 0.5834 | 0.9668 | 1.37 | 7.60 | 278,180.60 | -61.70 | -52.00 | -79.77 | -60.95 | 68.97 | 65.32 | -63.82 | -107.65 | 3.23 | -8.52 | 0.7387 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| Fonar Corp | 102.72m | 10.29m | 107.74m | 561.00 | 10.84 | 0.65 | 5.71 | 1.05 | 1.48 | 1.48 | 14.72 | 24.70 | 0.5023 | 19.99 | 1.41 | 183,098.20 | 7.16 | 8.73 | 7.40 | 9.60 | 45.55 | 48.33 | 14.26 | 16.39 | 9.16 | -- | 0.0051 | -- | 1.08 | 3.89 | -24.71 | -15.05 | 8.48 | -- |
| EUDA Health Holdings Ltd | 3.71m | -8.44m | 114.52m | 106.00 | -- | -- | -- | 30.90 | -0.3685 | -0.4384 | 0.1707 | -0.3045 | 0.2752 | -- | 3.55 | 34,966.61 | -62.62 | -- | -- | -- | 22.72 | -- | -227.57 | -- | -- | -1.49 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| KORU Medical Systems Inc | 29.32m | -13.27m | 116.24m | 82.00 | -- | 6.07 | -- | 3.96 | -0.2905 | -0.2905 | 0.6422 | 0.4181 | 0.8919 | 2.38 | 6.85 | 357,595.80 | -40.35 | -17.60 | -47.06 | -20.29 | 60.24 | 59.44 | -45.24 | -21.70 | 3.37 | -- | 0.0284 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| Harvard Bioscience, Inc. | 106.79m | -8.73m | 120.30m | 391.00 | -- | 1.75 | -- | 1.13 | -0.2029 | -0.2029 | 2.50 | 1.58 | 0.7662 | 1.74 | 6.46 | 273,112.50 | -6.26 | -3.29 | -7.60 | -3.89 | 58.52 | 56.67 | -8.18 | -4.57 | 0.9352 | -0.4017 | 0.341 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| DIH Holding US Inc | 60.30m | -1.77m | 122.85m | -- | -- | -- | -- | 2.04 | -0.0435 | -0.0435 | 1.49 | -0.8079 | -- | -- | -- | -- | -- | -- | -- | -- | 60.18 | -- | -2.93 | -- | 0.2656 | 1.50 | -- | -- | 12.15 | -- | 80.41 | -- | -- | -- |
| Electromed Inc | 53.50m | 4.36m | 126.55m | 170.00 | 29.58 | 2.97 | 24.44 | 2.37 | 0.4942 | 0.4942 | 6.08 | 4.92 | 1.17 | 3.31 | 2.25 | 314,682.30 | 9.49 | 7.86 | 11.03 | 9.14 | 76.41 | 76.25 | 8.14 | 7.38 | 5.87 | -- | 0.00 | 0.00 | 15.38 | 11.17 | 37.35 | 11.00 | 24.58 | -- |
| InfuSystem Holdings Inc | 127.41m | 84.00k | 139.91m | 499.00 | 2,363.31 | 2.68 | 11.38 | 1.10 | 0.0028 | 0.0028 | 5.91 | 2.46 | 1.23 | 10.66 | 6.57 | 255,330.70 | 0.0811 | 4.60 | 0.0955 | 5.69 | 50.27 | 56.43 | 0.0659 | 4.07 | 1.51 | 1.56 | 0.3641 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Clearpoint Neuro Inc | 26.16m | -20.63m | 147.25m | 107.00 | -- | 4.26 | -- | 5.63 | -0.8326 | -0.8326 | 1.05 | 1.26 | 0.5037 | 1.26 | 10.08 | 244,495.30 | -39.71 | -34.75 | -49.90 | -39.67 | 57.10 | 64.75 | -78.84 | -76.91 | 2.61 | -- | 0.2237 | -- | 16.56 | 26.64 | -34.40 | -- | 75.30 | -- |
| Stereotaxis Inc | 27.10m | -21.22m | 147.93m | 122.00 | -- | 10.09 | -- | 5.46 | -0.2575 | -0.2575 | 0.3288 | 0.2439 | 0.6012 | 1.45 | 6.14 | 222,155.70 | -44.08 | -25.02 | -63.05 | -34.12 | 55.16 | 67.57 | -73.32 | -41.90 | 1.79 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Trubridge Inc | 336.45m | -50.22m | 167.93m | 3.22k | -- | 0.9064 | -- | 0.4991 | -3.53 | -3.53 | 23.68 | 12.35 | 0.7886 | 160.45 | 5.66 | 104,519.70 | -12.05 | 1.25 | -13.58 | 1.41 | 48.45 | 50.40 | -15.27 | 1.56 | 1.93 | 0.9211 | 0.5002 | 45.06 | 3.91 | 3.89 | -387.73 | -- | 88.71 | -- |
| 908 Devices Inc. | 50.73m | -34.79m | 168.29m | 230.00 | -- | 1.02 | -- | 3.32 | -1.07 | -1.07 | 1.56 | 4.77 | 0.2486 | 1.67 | 6.48 | 220,578.30 | -17.04 | -14.16 | -18.79 | -15.35 | 51.13 | 53.02 | -68.56 | -64.25 | 7.53 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| Accuray Inc | 430.55m | -21.49m | 171.69m | 1.02k | -- | 4.18 | -- | 0.3988 | -0.2197 | -0.2197 | 4.42 | 0.4139 | 0.9178 | 1.86 | 5.72 | 420,462.90 | -4.58 | -1.45 | -7.84 | -2.48 | 33.06 | 37.86 | -4.99 | -1.62 | 0.778 | -0.3857 | 0.8086 | -- | 4.12 | 2.03 | -73.56 | -- | 13.92 | -- |
Data as of Jul 03 2024. Currency figures normalised to InfuSystem Holdings Inc's reporting currency: US Dollar USD
44.08%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| AWM Investment Co., Inc.as of 31 Mar 2024 | 1.90m | 8.92% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 1.07m | 5.02% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.05m | 4.91% |
| Punch & Associates Investment Management, Inc.as of 31 Mar 2024 | 959.66k | 4.51% |
| Minerva Advisors LLCas of 31 Mar 2024 | 846.85k | 3.98% |
| Wasatch Advisors LPas of 31 Mar 2024 | 846.61k | 3.98% |
| Meros Investment Management L.P.as of 31 Mar 2024 | 780.25k | 3.66% |
| Ranger Investment Management LPas of 31 Mar 2024 | 715.55k | 3.36% |
| Harbert Fund Advisors, Inc.as of 31 Mar 2024 | 618.09k | 2.90% |
| First Eagle Investment Management LLCas of 31 Mar 2024 | 605.24k | 2.84% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
